ConductScience.org, home

Paper8044938

Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.

Tomai F and 7 others. Circulation, 1994. Cited by 400 papers, by iCite.

Cite this record

ConductScience Library. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Papers, record 8044938. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8044938

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker.
PubMed
Journal
Circulation
PubMed
Year
1994
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
400
iCite
Relative citation ratio, by iCite
12.8
iCite
Revised in PubMed
2023-10-24
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tomai FF
2Crea FF
3Gaspardone AA
4Versaci FF
5De Paulis RR
6Penta de Peppo AA
7Chiariello LL
8Gioffrè PAP A

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenosine TriphosphateMajor topic
Angioplasty, Balloon, CoronaryMajor topic
Calcium Channel BlockersMajor topic
Calcium ChannelsMajor topic
GlyburideMajor topic
Myocardial IschemiaMajor topic
Blood Glucose
Coronary Circulation
Electrocardiography
Female
Humans
Male
Middle Aged
Monitoring, Physiologic
Single-Blind Method

Source PubMed

Download CSV of topics

Cited by76

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 400 citations.

PMIDTitleJournalYearIn PapersSource
38918852The causal relationship between anti-diabetic drugs and gastrointestinal disorders: a drug-targeted mendelian randomization study.Diabetol Metab Syndr2024https://conductscience.org/library/papers/38918852PubMed
38234711Adenosine Receptor Subtypes and Cardioprotection.Drug Dev Res1998https://conductscience.org/library/papers/38234711PubMed
38226326Validation of Blood Glucose and Lipid-Lowering Effect of Solvent Fractions of the Crinum Abyssinicum Shoot Tips in Streptozotocin-Induced Diabetic Mice.Glob Adv Integr Med Health2024https://conductscience.org/library/papers/38226326PubMed
38028722Sevoflurane-mediated modulation of oxidative myocardial injury.J Cardiovasc Thorac Res2023https://conductscience.org/library/papers/38028722PubMed
36592075Effects of Remote Ischemic Preconditioning on Decreasing Troponin Release in Patients Not Taking Sulfonylureas After Cardiac Surgery - A Meta-Analysis.Braz J Cardiovasc Surg2023https://conductscience.org/library/papers/36592075PubMed
35136357Evaluation of Anti-Diabetic and Anti-Hyperlipidemic Activities of Hydro-Alcoholic Crude Extract of the Shoot Tips of Crinum abyssinicum Hochst. ex A. Rich (Amaryllidaceae) in Mice.J Exp Pharmacol2022https://conductscience.org/library/papers/35136357PubMed
33116953Hypoglycemic, Anti-Hyperglycemic and Anti-Hyperlipidemic Effects of Bersama abyssinica Fresen (Melianthaceae) Leaves' Solvent Fractions in Normoglycemic and Streptozotocin-Induced Diabetic Mice.J Exp Pharmacol2020https://conductscience.org/library/papers/33116953PubMed
32620851Myocardial ischaemia-reperfusion injury and cardioprotection in perspective.Nat Rev Cardiol2020https://conductscience.org/library/papers/32620851PubMed
32607006Evaluation of in vitro and in vivo Anti-Diabetic, Anti-Hyperlipidemic and Anti-Oxidant Activity of Flower Crude Extract and Solvent Fractions of Hagenia Abyssinica (Rosaceae).J Exp Pharmacol2020https://conductscience.org/library/papers/32607006PubMed
31276600Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study.Br J Clin Pharmacol2019https://conductscience.org/library/papers/31276600PubMed
30271452Antidiabetic Activities of Hydromethanolic Leaf Extract of Calpurnia aurea (Ait.) Benth. Subspecies aurea (Fabaceae) in Mice.Evid Based Complement Alternat Med2018https://conductscience.org/library/papers/30271452PubMed
29795806Ameliorative potential of conditioning on ischemia-reperfusion injury in diabetes.Cond Med2018https://conductscience.org/library/papers/29795806PubMed
29788955Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes.Cardiovasc Diabetol2018https://conductscience.org/library/papers/29788955PubMed
28594895ATP-sensitive potassium (KATP) channel openers diazoxide and nicorandil lower intraocular pressure by activating the Erk1/2 signaling pathway.PLoS One2017https://conductscience.org/library/papers/28594895PubMed
28545784Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.Trends Endocrinol Metab2017https://conductscience.org/library/papers/28545784PubMed
27431258Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies.Cardiovasc Diabetol2016https://conductscience.org/library/papers/27431258PubMed
27268470Cardiovascular effects of anti-diabetes drugs.Expert Opin Drug Saf2016https://conductscience.org/library/papers/27268470PubMed
26535899Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems.PLoS One2015https://conductscience.org/library/papers/26535899PubMed
26287407Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease.Medicine (Baltimore)2015https://conductscience.org/library/papers/26287407PubMed
25205223Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study.Diabetologia2015https://conductscience.org/library/papers/25205223PubMed

See all 76 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8044938

GET https://conductscience.org/api/papers/v1/8044938/cited_by?page=2